Viome Life Sciences was founded with a mission to make illness optional.
A world class team focused on a single mission: help people live a healthy, disease-free life.
Viome Life Sciences was founded in 2016 with a mission to make illness optional by predicting, reversing, and preventing chronic diseases, cancer, and aging through a deeper understanding of an individual's biology.
We provide the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need.
Viome Life Sciences' Health Sciences division focuses on four key initiatives including prediction, early diagnostics, prognostics, and precision therapeutics. With our state-of-the-art AI platform, we analyze data from the world’s largest and richest gene expression database in order to identify the root causes of chronic diseases and the mechanisms of action to be able to prevent and reverse these diseases.
Learn more at www.viomelifesciences.com
Our Leadership Team
Chief Executive Officer
Naveen is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation.
Chief Technology Officer
Guru is a leader in Artificial Intelligence and Distributed Systems technologies. He is proud to have led the creation of Watson AI technologies at IBM. He is now excited to apply these technologies to enhance your wellness!
Stephen is a physician, scientist and entrepreneur and one of the founding pioneers in the microbiome field. His life has been dedicated to providing tools and information for people to improve their health.
Chief Operating Officer
John is an eCommerce and Operations leader who has spent the last 20+ years delivering customer-focused experiences on a global scale. He has a background in computer science, bioinformatics, marketing, supply chain, analytics, operations, and most recently held leadership roles at Amazon and Groupon.
Chief Science Officer
Momo brings more than 25 years of R&D experience in many scientific disciplines. He was most recently a scientist and leader of the Applied Genomics team at Los Alamos National Laboratory, where he successfully managed large national and international collaborations.
Global Head of R&D
As global head of R&D for the vaccine group at GSK, Dr. Hanon oversaw more than 3,500 employees across 50 countries dedicated to delivering discovery, development and management activities for the company's vaccine efforts. Dr. Hanon was responsible for the shared science and technology platforms supporting the entire vaccine business, managing technical development, clinical immunology, and preclinical stages of vaccine developments.
Our Scientific & Business Advisory Board
W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of Division of Pediatric Gastroenterology and Nutrition.
Andrew McCallum is Professor and Director of the Information Extraction and Synthesis Laboratory, as well as Director of Center for Data Science in the College of Information and Computer Science at University of Massachusetts Amherst.
Inventor, thinker, computer scientist, entrepreneur, New York Times bestselling author and Google’s Chief Futurist.
Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry. Executive Director of G. Oppenheimer Center for Neurobiology of Stress and Resilience, and Co-director of CURE: Digestive Diseases Research Center.
Gilles J. Guillemin
Gilles J. Guillemin is the Co-funder of the MND and Neurodegenerative Diseases Research Centre, the Co-funder of the Macquarie University MND Biobank and the Head of the Neuroinflammation group at Macquarie University.
George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science.
Sanjiv Chopra, MD, is a Professor of Medicine and served as Faculty Dean for Continuing Medical Education at Harvard Medical School for 12 years. He serves as a Marshall Wolf Master Clinician Educator Brigham and Women’s Hospital.
Stan Lapidus is an experienced life-science entrepreneur and inventor with over 30 issued U.S. patents. He founded SynapDX, a new company developing diagnostic tests for the early detection of autism, and currently serves as President and CEO. Prior to SynapDX, Stan founded and led Cytyc, EXACT Sciences and Helicos BioSciences, and holds academic appointments at Tufts and MIT.
Throughout his career as a dentist, Dr. Edward Zuckerberg was a pioneer in the integration of technology in the dental office. He now uses his vast experience to help other dental practices use social media and new technology to grow and promote their own businesses.
Karen Kempner is an American psychiatrist.
Deepak Chopra MD, FACP, founder of The Chopra Foundation and Chopra Global is a world-renowned pioneer in integrative medicine and personal transformation. Dr. Chopra is Board Certified in Internal Medicine, Endocrinology and Metabolism, a Fellow of the American College of Physicians, and a member of the American Association of Clinical Endocrinologists. He serves as a Clinical Professor of Medicine at the University of California, San Diego. He is the author of over 90 books including numerous New York Times bestsellers. TIME magazine has described Dr. Chopra as "one of the top 100 heroes and icons of the century."
Vishen Lakhiani is a Malaysian entrepreneur, author, and motivational speaker. He is the founder and CEO of Mindvalley and the author of The Code of the Extraordinary Mind and The Buddha and the Badass.
For press related inquiries
Please email: firstname.lastname@example.org
We are hiring!
Together we can create a world where we make illness elective!